Alpine Immune Sciences Inc

NASDAQ:ALPN   3:59:53 PM EDT
9.04
+0.53 (+6.23%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)274.17M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.04 Million
Adjusted EPS-$0.38
See more estimates
10-Day MA$8.35
50-Day MA$8.62
200-Day MA$9.98
See more pivots

Alpine Immune Sciences Inc Stock, NASDAQ:ALPN

188 East Blaine Street, Suite 200, Seattle, Washington 98102
United States of America
Phone: +1.206.788.4545
Number of Employees: 85

Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovery of protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.